InsiderClue
Insiders · Profile

TABUTEAU HERRIOT

Chief Executive Officer at Axsome Therapeutics. Filing since 12 Sep 2025. CIK 0001219927

Company
Date
Role
Action
Shares
Amount
Of holding
AXSM Axsome Therapeutics, Inc.
6 Aug 2026
Chief Executive Officer
Sold on a plan
4,660
$997.01K
39.2%
AXSM Axsome Therapeutics, Inc.
5 Aug 2026
Chief Executive Officer
Sold on a plan
45,004
$9.54M
86.2%
AXSM Axsome Therapeutics, Inc.
1 Jul 2026
Chief Executive Officer
Sold on a plan
49,666
$11.93M
87.3%
AXSM Axsome Therapeutics, Inc.
9 Jun 2026
Chief Executive Officer
Sold on a plan
49,670
$11.97M
87.3%
AXSM Axsome Therapeutics, Inc.
2 Feb 2026
Chief Executive Officer
Sold on a plan
32,410
$6.02M
81.8%
AXSM Axsome Therapeutics, Inc.
7 Jan 2026
Chief Executive Officer
Sold on a plan
31,261
$5.33M
81.2%
AXSM Axsome Therapeutics, Inc.
6 Jan 2026
Chief Executive Officer
Sold on a plan
29,450
$5.08M
80.3%
AXSM Axsome Therapeutics, Inc.
5 Jan 2026
Chief Executive Officer
Sold on a plan
78,703
$13.48M
91.6%
AXSM Axsome Therapeutics, Inc.
4 Dec 2025
Chief Executive Officer
Sold on a plan
10,558
$1.56M
59.4%
AXSM Axsome Therapeutics, Inc.
3 Dec 2025
Chief Executive Officer
Sold on a plan
20,163
$2.96M
73.6%
AXSM Axsome Therapeutics, Inc.
2 Dec 2025
Chief Executive Officer
Sold on a plan
49,252
$7.12M
87.2%
AXSM Axsome Therapeutics, Inc.
5 Nov 2025
Chief Executive Officer
Sold on a plan
21,775
$2.93M
75.1%
AXSM Axsome Therapeutics, Inc.
4 Nov 2025
Chief Executive Officer
Sold on a plan
50,459
$6.75M
87.5%
AXSM Axsome Therapeutics, Inc.
3 Nov 2025
Chief Executive Officer
Sold on a plan
91,705
$12.14M
92.7%
AXSM Axsome Therapeutics, Inc.
8 Oct 2025
Chief Executive Officer
Sold on a plan
12,774
$1.52M
63.9%
AXSM Axsome Therapeutics, Inc.
7 Oct 2025
Chief Executive Officer
Sold on a plan
13,390
$1.59M
64.9%
AXSM Axsome Therapeutics, Inc.
6 Oct 2025
Chief Executive Officer
Sold on a plan
19,220
$2.31M
72.7%
AXSM Axsome Therapeutics, Inc.
16 Sep 2025
Chief Executive Officer
Sold on a plan
19,719
$2.25M
73.2%
AXSM Axsome Therapeutics, Inc.
15 Sep 2025
Chief Executive Officer
Sold on a plan
15,254
$1.79M
67.8%
AXSM Axsome Therapeutics, Inc.
12 Sep 2025
Chief Executive Officer
Sold on a plan
27,907
$3.32M
79.4%
20 decisions on file.